SLG
HALO icon

Stanley-Laman Group’s Halozyme HALO Stock Holding History

Stanley-Laman Group’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-63,196
Closed -$2.52M – 289
2022
Q1 		$2.52M Sell
63,196
-3,263
-5% -$116K 0.35% 104
2021
Q4 		$2.67M Buy
+66,459
New +$2.48M 0.31% 104

Other funds holding HALO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Stanley-Laman Group's HALO Position: Q2 2022 in Review

Stanley-Laman Group sold out of Halozyme (HALO) in Q2 2022, closing a stake of 63,196 shares — an estimated $2.52M sold.

Stanley-Laman Group first reported a position in HALO in Q4 2021 and held it in 2 quarters. The position peaked at $2.67M in Q4 2021. 367 funds tracked by Wall St. Rank hold HALO as of Q2 2022.

  • Stanley-Laman Group reported no remaining Halozyme position as of Q2 2022 after selling out during the quarter.
  • Stanley-Laman Group sold 63,196 Halozyme shares in Q2 2022, an estimated $2.52M.
  • Stanley-Laman Group first reported a position in Halozyme in Q4 2021 and held it in 2 quarters.
  • Stanley-Laman Group's Halozyme position peaked at $2.67M in Q4 2021.
  • 367 funds tracked by Wall St. Rank held Halozyme as of Q2 2022.

Based on Stanley-Laman Group's 13F filing for Q2 2022, filed 8 Aug 2022.